NCT04462627View on ClinicalTrials.gov

Reduction of COVID 19 Transmission to Health Care Professionals

NACompletedINTERVENTIONAL

Enrollment

566

Participants

Timeline

Start Date

April 14, 2020

Primary Completion Date

April 11, 2022

Study Completion Date

April 11, 2022

Conditions

COVID 19

Interventions

DIAGNOSTIC_TEST

Blood group determination

Determination of the blood group (ABO/LE)

DIAGNOSTIC_TEST

Antibody titration

Natural anti-A and anti-B antibody levels will be determined by a gel agglutination technique on the Biorad IH-500 automaton.

DIETARY_SUPPLEMENT

Probiotic

Administration of a probiotic to healthy volunteers to determine if it increases the level of circulating natural anti-A and anti-B antibodies (Probactiol Plus (Metagenics)).

Trial Locations (1)

1020

CHU Brugmann, Brussels

All Listed Sponsors

lead

Hanane EL KENZ

OTHER

NCT04462627 - Reduction of COVID 19 Transmission to Health Care Professionals | Biotech Hunter | Biotech Hunter